Phillip A. Sharp

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: Brett Budzinski, Attorney-in-Fact For: Phillip A. Sharp
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Phillip A. Sharp

Form 4 holding Director

Vir Biotechnology, Inc.

Security class
Common Stock
Shares / value
121,174
Estimated value
$185,396
Report date
22 May 2023
Price
$1.53
Ownership
Direct
Form 4 holding Director

Vir Biotechnology, Inc.

Security class
Common Stock
Shares / value
44,444
Estimated value
$67,999
Report date
22 May 2023
Price
$1.53
Ownership
Indirect
Form 4 holding Director

Vir Biotechnology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
12,054
Estimated value
$18,443
Report date
22 May 2023
Price
$1.53
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Syros Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
17,500
Estimated value
Report date
01 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ALNYLAM PHARMACEUTICALS, INC.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
23 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Phillip A. Sharp

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .